α-Synuclein and the lewy body disorders

Research output: Contribution to journalArticle

139 Citations (Scopus)

Abstract

α-Synuclein has risen to prominence during the past 5 years because of its association with several neurodegenerative diseases that have come to be known as the synucleinopathies. The clinical phenotype of the synucleinopathies is variable, with the most common being parkinsonism, autonomic dysfunction, and dementia. Progress has been made in clinical, neuropathologic and biochemical characterization of the synucleinopathies and their differentiation from other neurodegenerative disorders. At the molecular level, the synucleinopathies have conformational and post-translational modifications of synuclein that favor its fibrillization and aggregation in inclusions in neurons and gila. Whether inclusion body formation is an adaptive response or is directly related to degeneration of neuronal and glial cells is a topic of current research.

Original languageEnglish (US)
Pages (from-to)423-432
Number of pages10
JournalCurrent Opinion in Neurology
Volume14
Issue number4
DOIs
StatePublished - 2001

Fingerprint

Synucleins
Lewy Bodies
Neurodegenerative Diseases
Inclusion Bodies
Parkinsonian Disorders
Post Translational Protein Processing
Neuroglia
Dementia
Phenotype
Neurons
Research

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

α-Synuclein and the lewy body disorders. / Dickson, Dennis W.

In: Current Opinion in Neurology, Vol. 14, No. 4, 2001, p. 423-432.

Research output: Contribution to journalArticle

@article{510c4d5fa2aa491fa4d23c3e7065c654,
title = "α-Synuclein and the lewy body disorders",
abstract = "α-Synuclein has risen to prominence during the past 5 years because of its association with several neurodegenerative diseases that have come to be known as the synucleinopathies. The clinical phenotype of the synucleinopathies is variable, with the most common being parkinsonism, autonomic dysfunction, and dementia. Progress has been made in clinical, neuropathologic and biochemical characterization of the synucleinopathies and their differentiation from other neurodegenerative disorders. At the molecular level, the synucleinopathies have conformational and post-translational modifications of synuclein that favor its fibrillization and aggregation in inclusions in neurons and gila. Whether inclusion body formation is an adaptive response or is directly related to degeneration of neuronal and glial cells is a topic of current research.",
author = "Dickson, {Dennis W}",
year = "2001",
doi = "10.1097/00019052-200108000-00001",
language = "English (US)",
volume = "14",
pages = "423--432",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - α-Synuclein and the lewy body disorders

AU - Dickson, Dennis W

PY - 2001

Y1 - 2001

N2 - α-Synuclein has risen to prominence during the past 5 years because of its association with several neurodegenerative diseases that have come to be known as the synucleinopathies. The clinical phenotype of the synucleinopathies is variable, with the most common being parkinsonism, autonomic dysfunction, and dementia. Progress has been made in clinical, neuropathologic and biochemical characterization of the synucleinopathies and their differentiation from other neurodegenerative disorders. At the molecular level, the synucleinopathies have conformational and post-translational modifications of synuclein that favor its fibrillization and aggregation in inclusions in neurons and gila. Whether inclusion body formation is an adaptive response or is directly related to degeneration of neuronal and glial cells is a topic of current research.

AB - α-Synuclein has risen to prominence during the past 5 years because of its association with several neurodegenerative diseases that have come to be known as the synucleinopathies. The clinical phenotype of the synucleinopathies is variable, with the most common being parkinsonism, autonomic dysfunction, and dementia. Progress has been made in clinical, neuropathologic and biochemical characterization of the synucleinopathies and their differentiation from other neurodegenerative disorders. At the molecular level, the synucleinopathies have conformational and post-translational modifications of synuclein that favor its fibrillization and aggregation in inclusions in neurons and gila. Whether inclusion body formation is an adaptive response or is directly related to degeneration of neuronal and glial cells is a topic of current research.

UR - http://www.scopus.com/inward/record.url?scp=84940364788&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940364788&partnerID=8YFLogxK

U2 - 10.1097/00019052-200108000-00001

DO - 10.1097/00019052-200108000-00001

M3 - Article

VL - 14

SP - 423

EP - 432

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 4

ER -